Links to the publications that use this peptide:
Sun HJ, Chen D, Han Y, et al. Relaxin in paraventricular nucleus contributes to sympathetic overdrive and hypertension via PI3K-Akt pathway. Neuropharmacology. 2016;103:247-56.
Zhang X, Ma X, Zhao M, et al. H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes.
Biochimie. 2015;108:59-67.
Pimenta MT, Francisco RA, Silva RP, Porto CS, Lazari MF. Relaxin affects cell organization and early and late stages of spermatogenesis in a coculture of rat testicular cells.
Andrology. 2015;3(4):772-86.
Dschietzig T, Alexiou K, Kinkel HT, Baumann G, Matschke K, Stangl K. The positive inotropic effect of relaxin-2 in human atrial myocardium is preserved in end-stage heart failure: role of G(i)-phosphoinositide-3 kinase signaling.
J Card Fail. 2011;17(2):158-66.
Ferlin A, Pepe A, Facciolli A, Gianesello L, Foresta C. Relaxin stimulates osteoclast differentiation and activation.
Bone. 2010;46(2):504-13.
Dschietzig T, Bartsch C, Wessler S, Baumann G, Stangl K. Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter.
Regul Pept. 2009;155(1-3):163-73.
